Study guide
11.2 Performing Blood Gas Analysis
NBRC Registered Pulmonary Function Technologist RPFT
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Content Outline Domains & Study Plan
2 Spirometry Instrumentation
2.1 Spirometer Types, Setup & Maintenance 2.2 Spirometer Calibration & Linearity 2.3 Spirometer Troubleshooting
3 Blood Gas & Gas Analyzers
3.1 Blood Gas Analyzer Setup, Maintain, Calibrate 3.2 Gas Analyzers & Water/Gas Absorbers 3.3 ABG & Gas Analyzer Troubleshooting and QC
4 Body Box, Exercise & Monitoring Equipment
4.1 Body Plethysmograph Setup & Calibration 4.2 Exercise, Field Walking & ECG Equipment 4.3 Pressure Devices, Valves & Gas Delivery Systems
5 Ancillary Equipment & Infection Control
5.1 Body Habitus, Sampling & Aerosol Equipment 5.2 Monitors & Emergency Management Equipment 5.3 Infection Control Materials & Methods
6 Quality Control Systems
6.1 Mechanical QC Devices 6.2 Biological Controls & Proficiency Testing 6.3 Laboratory Quality Management & SOPs
7 Patient Preparation & Safety
7.1 Body Habitus Measurements & Estimates 7.2 Patient Safety, Precautions & Adverse Events
8 Spirometry Procedures
8.1 Selecting Spirometry Protocols & Equipment 8.2 Performing Standard & Position-Variant Spirometry 8.3 Evaluating Spirometry Acceptability & Repeatability 8.4 Bronchodilator Response Studies
9 Static Lung Volumes
9.1 Gas Dilution Lung Volume Methods 9.2 Body Plethysmography Lung Volumes 9.3 Evaluating Lung Volume Validity
10 Diffusing Capacity (DLCO)
10.1 DLCO Protocol & Equipment Selection 10.2 Performing the DLCO Maneuver 10.3 Evaluating DLCO Validity
11 Blood Gas Sampling & Analysis Procedures
11.1 Arterial & Capillary Blood Sample Collection 11.2 Performing Blood Gas Analysis 11.3 CO-oximetry / Hemoximetry Procedures
12 Airway Responsiveness, Resistance & Muscle Strength
12.1 Bronchial Provocation Studies 12.2 Airways Resistance & Conductance by Plethysmography 12.3 Respiratory Muscle Strength (MIP/MEP/CPF)
13 Exercise, Oxygen, Home Testing & Education
13.1 Field Walking Tests (6MWT, Shuttle) 13.2 Monitored Exercise Testing 13.3 Oxygen Assessment & Titration 13.4 Home Testing Instruction & Patient Education
14 Calculations & Reference Ranges
14.1 Spirometry Calculations & Reference Equations 14.2 Lung Volume & DLCO Calculations/Corrections 14.3 Blood Gas & CO-oximetry Derived Calculations 14.4 Exercise, Oximetry & Special Test Calculations
15 Evaluating Result Reliability
15.1 Spirometry & Lung Volume Reliability 15.2 DLCO & Exercise Test Reliability 15.3 ABG, Monitoring & QC Reliability
16 Clinical Implications & Reporting
16.1 Pattern Recognition: Obstruction, Restriction, Mixed, Severity 16.2 Clinical Implications: DLCO, ABG, Airway Response, Exercise & Lab Context
11.2 Performing Blood Gas Analysis
Key Takeaways Explain This Topic AI
Analyze ABG samples only on a calibrated, QC-passed analyzer at controlled temperature near 37 °C after remixing the specimen and confirming no clots or residual air.
pH, PCO2, and PO2 are measured (electrode or equivalent sensor); HCO3−, base excess, and many SaO2 displays are calculated—do not treat calculated saturation as measured oxyhemoglobin fraction.
Critical or extreme values require technologist verification: check sample integrity, repeat analysis or redraw per policy, and escalate critical results through the lab’s reporting pathway.
Domain II tasks for analysis map to selecting the pathway (II.A.6), performing the run (II.B.6), and judging validity of the result set (II.C.6).
Document FiO2/device, patient temperature when required for correction policies, and time-to-analysis so clinical interpretation of PO2 and acid–base status is contextualized.
Last updated: August 2026
From syringe to report: the analysis procedure
Chapter 3 covered instrumentation (electrodes, warm-up, calibration, QC). Section 11.2 is the Domain II handoff: once a specimen arrives, the RPFT must select the correct analysis pathway ( II.A.6 ), perform the run ( II.B.6 ), and evaluate validity of outputs ( II.C.6 ). Form construction may limit pure “blood gas analysis” scored items (often a small maximum per form), but the procedure still integrates with sampling validity and with clinical data management later in Domain III.
Pre-analytical acceptance at the analyzer
Before introducing blood:
Instrument ready state: temperature stable near 37 °C , recent calibration valid, QC in control for the analytes you will report, no hard sensor or fluidic faults.
Specimen identity: labels match order and patient; FiO2 or oxygen delivery mode and flow recorded; draw time known.
Physical integrity: remix by gentle inversion; inspect for clots , layers , or air ; if air remains, expel before aspiration into the analyzer if still within integrity rules—otherwise redraw.
Volume: meet the analyzer’s minimum for the panel ordered (blood gas only versus blood gas + co-oximetry).
Time/temperature history: if the sample sat warm beyond policy, or icing rules were violated for your syringe type, reject and redraw rather than reporting questionable gases.
Exam mindset: The technologist is the last gate before a wrong number reaches a chart.
- Running the sample
- Temperature control
Blood gas pH and gas partial pressures are temperature-dependent . Analyzers measure at a controlled 37 °C (or apply defined corrections). Introducing a cold sample into a warm measuring chamber is expected; the instrument brings the aliquot to measuring temperature. What must not happen is analyzing on a machine that has not reached thermal equilibrium after startup or service—readings will bias across pH, PCO2, and PO2.
Some labs optionally report temperature-corrected values when patient temperature is far from 37 °C (hypothermia/hyperthermia). Know your lab’s policy: many clinical decisions use 37 °C measured values with clinical context rather than corrected sets. If correction is used, patient temperature must be entered correctly.
Mixing and introduction
Remix immediately before analysis so cells and plasma are uniform (important for co-ox and calculated indices).
Follow the device workflow: syringe adapter versus capillary mode; select the correct sample type if the menu distinguishes arterial/venous/capillary.
Avoid introducing foam or residual bubbles into the measuring path.
After analysis, review flags (air detect, clot, short sample, drift) before releasing results.
Analyzer acceptance of the result
Modern systems may auto-repeat or flag outliers. The technologist still applies validity judgment :
Internal consistency (e.g., extremely high PO2 on room air with normal clinical context → suspect air contamination or wrong FiO2 documentation).
Comparison with recent results and SpO2 when available (not as a hard rule, but as a reasonableness check).
Sensor/QC status for that channel.
Measured versus calculated parameters
Memorize this distinction—it is high-yield for RPFT and for avoiding over-interpretation of printouts.
- Parameter Typically Notes for the exam
- pH Measured Glass electrode or equivalent; primary acid–base value
- PCO2 Measured Severinghaus-type or equivalent CO2 sensor
- PO2 Measured Clark polarographic or equivalent O2 sensor
- HCO3− (bicarbonate) Calculated From pH and PCO2 via Henderson–Hasselbalch relationship
- Base excess (BE) / base deficit Calculated Algorithm using pH, PCO2 (±Hb); reflects metabolic component
SaO2 / O2 sat on many ABG panels Estimated/calculated Often from PO2 and pH (oxyhemoglobin dissociation assumptions)— not the same as multiwavelength FO2Hb
FO2Hb, FCOHb, FMetHb, etc. Measured on CO-oximeter Requires hemoximetry module/device (Section 11.3)
Critical teaching point: A “normal” calculated saturation can coexist with high carboxyhemoglobin because pulse oximeters and PO2-based estimates do not correctly quantify COHb. When dyshemoglobins matter, order CO-oximetry , not ABG alone.
Immediate critical value recognition
Laboratories define critical (panic) values —examples often include very low or high pH , extreme PCO2 , life-threatening PO2 , or unexpected extremes relative to age and support. Exact numeric cutoffs are lab-specific ; the RPFT skill is the process :
Stop and verify before reflexive charting: sample integrity, patient ID, FiO2, analyzer flags, possible air/clot/heparin issues.
Repeat analysis on the same specimen if volume and policy allow and integrity looks intact.
Redraw if pre-analytical error is likely (air, delay, mislabel risk, clot).
Notify per critical-result policy (licensed provider, documented read-back).
Do not “average away” an extreme with a normal without a documented reason—investigate first.
Extreme patterns that should trigger technologist suspicion:
Room-air PO2 > ~120–150 mm Hg without supplemental O2 documentation → air contamination or wrong clinical data.
PCO2 near 0 or impossibly low with normal clinical status → air, dilution, or sensor failure.
pH incompatible with life without matching clinical emergency → instrument or sample error until proven otherwise.
Sudden large change from a sample drawn minutes earlier without clinical event → pre-analytical or analytic fault.
Putting II.A.6 / II.B.6 / II.C.6 together
Outline lens Technologist behaviors
Select (II.A.6) Choose ABG versus CBG pathway; decide whether co-ox is also required; select correct analyzer mode and panel
Perform (II.B.6) Remix, introduce sample, run at 37 °C on in-control instrument, document context
Validity (II.C.6) Accept/reject based on flags, consistency, QC status, critical-value verification, and redraw rules
Related practice sets: /practice/rpft . Clinical interpretation of acid–base patterns is expanded in Domain III chapters; here the job is produce a defensible measured panel .